Engr. Biser Georgiev, Executive Director: With a market cap of over BGN 1 billion Tchaikapharma remains the most expensive public company
We say goodbye to a historic year, marked by unprecedented difficulties in medical, economical, political and of course, in pure human terms. With hard work and effective oganization, in this difficul
22 December, 2020Tchaikapharma remains the most expensive company
Tchaikapharma High Quality Medicines Inc. remains the most expensive Bulgarian company on the Bulgarian Stock Exchange. After the market capitalization of the pharmaceutical company exceeded BGN 1 bil
09 October, 2020Tchaikapharma retains its position as the most expensive Bulgarian company
Tchaikapharma High Quality Medicines retains its position as the most expensive Bulgarian company on the BSE. After the players on the stock exchange estimated the pharmaceutical company at BGN 1,027,
04 August, 2020There is a company on the BSE with a value of over one billion leva – this is Tchaikapharma!
There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma H
13 July, 2020Another increase of Tchaikapharma’s share price early this week
Tchaikapharma High Quality Medicines’ shares increased by 1.8% at the end of the trading Monday, March 23, and the closing price reached BGN 11.60. Since the beginning of the year, the company h
23 March, 2020Tchaikapharma – a remarkable presence on the Bulgarian capital market
In the past year, Tchaikapharma has consolidated its leading position through the successful development of numerous scientific projects, the basis of which is advanced research work on the developmen
07 January, 2020Strongly Investable Tchaikapharma Today (3rd September 2018)
Distant leader in the treatment of cardiovascular disease among all drug manufacturers present on the Bulgarian market with market share 10.57% in 2017 and 11.39% for the first half of 2018 (Source:
03 September, 2018FSC entered the issue of shares after Tchaikapharma’s capital increase
The Financial Supervision Commission (FSC) registered the shares issued by Tchaikapharma High Quality Medicines Inc. as a result of an increase of the company’s capital with a view to trading on
25 August, 2017Tchaikapharma increased its capital by BGN 7.7 million
The current capital of the pharmaceutical company is BGN 64.3 million. Tchaikapharma High Quality Medicines Inc. announced that following the entry in the Commercial Register the capital of the compan
14 July, 2017Tchaikapharma held its regular General Meeting of Shareholders
The voted dividend for 2016 is 7 700 000. The amount of the capital after the increase is BGN 64 300 000. On June 8, 2017, the Annual General Meeting of Shareholders (GMS) of Tchaikapharma High Quali
09 June, 2017Appointment of a new Investment Relations Director
On the basis of art.27, par.1. it. 2 of the Ordinance No. 2 of the Financial Supervision Commission (FSC), we notify the following circumstances relating to Tchaikapharma High Quality Medicines Inc.,
04 April, 2017Letter to Shareholders
The outgoing 2016 was a wonderful year of continued progress for Tchaikapharma. It was the first full year since Tchaikapharma was listed as a public company on the Bulgarian Stock Exchange (BSE) in S
07 December, 2016Tchaikapharma became the largest public company in Bulgaria
The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companie
09 September, 2016Tchaikapharma is among the best investments on BSE for 2016
A total of 8 among the 40 companies included in calculating one of the main indicators of the Bulgarian Stock Exchange – BGBX40, rose more than 10%, and nine companies lose between 13 and 58% of
08 August, 2016Tchaikapharma held its Annual General Meeting of shareholders
By decision of the General Meeting, the company’s capital will be increased by BGN 7 million, which will increase in proportion the number of shares that each shareholder has. On 23rd June 2016,
24 June, 2016The Annual General Meeting of Tchaikapharma’s shareholders will take place on 23rd of June 2016
For the past year the company has reported improved results in its financial performance, introducing new products and entering new markets, as well as advancing in the field of its research and devel
22 June, 2016Invitation to the General Shareholders Meeting
Tchaikapharma High Quality Medicines Inc. invites all of the shareholders of the Company to the Annual General Meeting which will be held on 23 June 2016. You can find the full invitation wording here
27 April, 2016Tchaikapharma’s shares rose in value by 1.21% on Thursday
At the end of the trading day (Thursday 7 April) Tchaikapharma’s shares rose most significantly – they increased by 1.21% and the closing price reached BGN 5.85. This represents another appreciation o
08 April, 2016Tchaikapharma’s shares reached their highest value in the public history of the company
Tchaikapharma High Quality Medicines Inc. successfully launched the trading week. On Monday, the company ranked third in traded volume, having trading volume of nearly BGN 33.4 thousand. The transacti
23 March, 2016Tchaikapharma reported excellent financial results for the third quarter of 2015
The results of the third quarter of 2015 confirmed the optimistic forecasts for the financial results of Tchaikapharma High Quality Medicines Inc. Obviously the long-term strategy for innovative, high
30 October, 2015Tchaikapharma increases its shares on the BSE
With the decision of 25.05.2015, the Financial Supervision Commission confirmed the supplement to the prospectus for capital increase and the admission to trading of another 6.1 million shares of Tcha
26 May, 2015Growing interest in the shares of Tchaikapharma
Today is the second trading day of the shares of Tchaikapharma High Quality Medicines AD. The Bulgarian Stock Exchange transactions were concluded at higher levels compared to yesterday – BGN 4.
22 May, 2015The stock trade of Tchaikapharma in Sofia has started
The stock trade with the shares of Tchaikapharma High Quality Medicines AD has started at the Bulgarian Stock Exchange at the price of BGN 4.26 per share. The market closed with a demand for BGN 4.27
21 May, 2015Shares of Tchaikapharma High Quality Medicines AD will be introduced for trading on the 21st of May 2015
At a meeting of the Board of Directors of the Bulgarian Stock Exchange – Sofia AD, the following decision was taken in Protocol 19 / 13.05.2015: In connection with the submitted application purs
14 May, 2015The shares of Tchaikapharma are a step away from the Bulgarian Stock Exchange
Tchaikapharma High Quality Medicines AD has declared the admission to trading of its shares on the Bulgarian Stock Exchange, was confirmed by the operator. The ISIN code of the issue is BG1100008074.
13 May, 2015
